We report a rare presentation of Lemierre's syndrome in a 65‐year‐old woman, characterised by the coexistence of septic pulmonary emboli and pulmonary arterial thromboembolism, both documented on CT pulmonary angiography. ABSTRACT Lemierre syndrome (LS) is a rapidly progressing disease characterised by a recent oropharyngeal infection, complicated by ...
Antonio Fabozzi+5 more
wiley +1 more source
Integrated Traditional Chinese and Western Medicine in Lung Adenocarcinoma with Rare EGFR Mutation and Nephrotic Syndrome: A Case Report. [PDF]
Zhang L, Cai L, Ruan L, Li J.
europepmc +1 more source
Three Challenges in an Infant: Neuroblastoma Mimicking Infantile Hepatic Hemangioma, With Chylothorax and Rosettes in Pleural Fluid. [PDF]
Alavi S+4 more
europepmc +1 more source
A Case of Mesothelial‐Cell Inclusions in the Mediastinal Lymph Nodes After Lung Cancer Surgery
We reported, for the first time, a case of mesothelial‐cell inclusion (MCI) after lung cancer surgery. ABSTRACT Mesothelial‐cell inclusion (MCI) is an inclusion of mesothelial cells found in lymph nodes. Although it is a rare condition, differentiating it from lymph node metastasis is essential to avoid a misdiagnosis.
Hiroyuki Miura+3 more
wiley +1 more source
Driver mutations and malignant pleural effusion in non-small cell lung cancer. [PDF]
Temel U, Derdiyok O.
europepmc +1 more source
Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion
Eleanor K. Mishra+27 more
semanticscholar +1 more source
Tract Metastasis of Squamous Cell Carcinoma of the Lung
We present a case of a chest wall mass that developed at a previous chest drain insertion site, of which histology confirmed squamous cell carcinoma. This case highlights the potential for metastatic spread of malignancy via a chest drain tract. ABSTRACT A 78‐year‐old man with a history of haemothorax developed a chest wall mass at the site of a ...
Hai Quan Lee+3 more
wiley +1 more source
The role of <sup>18</sup>F-FDG PET/CT in patients with serous cavity effusion of undetermined origin: a retrospective clinical study. [PDF]
Hu X, Li Y, Cai J, Wang P.
europepmc +1 more source
The median progression‐free survival and overall survival periods were 5.9 (95% CI, 4.7–7.3) and 24.9 (95% CI, 16.8–28.1) months, respectively. Chemoimmunotherapy is an effective treatment for recurrent disease after chemoradiotherapy in patients with limited disease small cell lung cancer.
Ayako Shiono+22 more
wiley +1 more source
VATS combined with CT‐guided MWA is a safe and effective treatment option for patients with mGGOs. This hybrid surgical approach has broadened the treatment options available to thoracic surgeons and enhanced their procedural capabilities, marking an era in which surgeons can simultaneously use a needle and scalpel.
Bin Huang+15 more
wiley +1 more source